Cloud PR Wire

NanoViricides testing oral gummy and syrup Covid-19 treatment – Proactive Research Analyst

by July 13, 2023

–News Direct–

Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides Inc (NYSE-A:NNVC), a development-stage company that is creating special-purpose nanomaterials for antiviral therapy. Savin gives an overview of what the company does, as well as its current operations and its financial situation. He highlights that NanoViricides is currently undertaking its first ever clinical trial, of an edible treatment for Covid-19 in India.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/nanoviricides-testing-oral-gummy-and-syrup-covid-19-treatment-proactive-research-analyst-811701760

NanoViricides

comtex tracking

COMTEX_436780769/2655/2023-07-13T08:31:33

You may also like...